baber/WOPTO huggingface dataset:
Patent NZ-234795-A (NZ)
Title: Cosmetic composition characterised by a vehicle system comprising a water
Inventor: BOLICH RAYMOND EDWARD
IPC: A61K8/00
Filed: 1990-08-06
Abstract: Disclosed is a unique vehicle system which provides a desirable rheology to products formulated therewith, enhanced dispersion of actives therein, and improved deposition of actives therefrom. This vehicle system comprises a primary thickening agent which is a nonionic long-chain alkylated water-soluble polymer, and a secondary thickening agent which is a water-soluble surfactant, dispersed in a compatible solvent. Optionally, a rheological aid, which is a chelating agent may be included in the vehicle system. Also, optionally, a distributing aid, which is a water-soluble polymer of either high molecular weight or strong ionic character may be included in the vehicle system. These vehicle systems are useful in cosmetic compositions which are used to deliver an active component to the hair or skin. The vehicle systems are particularly useful in hair care compositions, especially rinse-off hair conditioning compositions, because they effectively deliver the hair conditioning component to the hair without depositing a substantial amount of the vehicle material onto the hair.
Patent NZ-237904-A (NZ)
Title: Gastric sustained release compositions comprising triclosan
Inventor: DETTMAR PETER WILLIAM
IPC: A61K9/46
Filed: 1991-04-22
Abstract: The use of triclosan for the preparation of medicaments for the treatment of gastrointestinal disorders associated with Helicobacter pylori infections is disclosed. The medicaments may be in the form of powders, granules, spheroids or liquids, or in unit dosage form as capsules or tablets containing 1 to 100mg, preferably 10 to 60mg, of triclosan. The medicaments may also be in gastric sustained release form as raft forming tablets or liquids, optionally to be co-administered with a solid pharmaceutically acceptable carboxylic acid or acid salt, or as muco-adherent-coated granules or spheroids.
Patent NZ-238750-A (NZ)
Title: Pyridopyazine derivatives for treating substance abuse and addiction
Inventor: BRIGHT GENE MICHAEL
IPC: C07D471/04
Filed: 1991-06-27
Abstract: Racemic or optically active pyrido[1,2-a]pyrazine derivatives of the formula   <IMAGE>   wherein X is N or CH and Y represents one of certain pyrazolo, triazolo, tetrazolo or cyclic imido radicals are useful in the treatment of abuse of and/or addiction to such substances as narcotics, alcohol and nicotine.
Patent NZ-241757-A (NZ)
Title: Treating cellulite with a retinoid
Inventor: KLIGMAN ALBERT MONTGOMERY
IPC: A61K31/185
Filed: 1992-02-27
Abstract: A method for retarding and reversing cellulite comprises topically applying to human skin a retinoid in an amount and for a period of time effective to retard or reverse cellulite where said amount is insufficient to be excessively irritating. The method preferably uses retinoic acid in an emollient vehicle.
Patent NZ-252359-A (NZ)
Title: Use of igf-1
Inventor: DUNGER DAVID B
IPC: A61P3/08
Filed: 1993-05-14
Abstract: PCT No. PCT/SE93/00425 Sec. 371 Date Feb. 1, 1994 Sec. 102(e) Date Feb. 1, 1994 PCT Filed May 14, 1993 PCT Pub. No. WO93/23071 PCT Pub. Date Nov. 25, 1993.The invention relates to the use of IGF-1 for the manufacture of a medicament for treatment of Type 1 diabetes mellitus. the medicament comprising a subcutaneous dose not greater than needed to achieve an IGF-1 serum level characteristic for healthy individuals i.e. a physiological replacement of serum IGF-1. This treatment would be especially valuable for the treatment of children or adolescents with Type 1 diabetes mellitus and could lead to improvements in their pubertal growth.
Patent NZ-252542-A (NZ)
Title: Compositions of blocking p-selectin antibodies and their use in treating inflammatory or thrombotic disease
Inventor: CHESTNUT ROBERT W
IPC: C12P21/08
Filed: 1993-05-04
Abstract: The present invention relates to compositions and methods for treating inflammation and other pathological conditions using novel blocking P-selectin antibodies which inhibit binding of an antibody secreted by a cell line designated ATCC Accession No. HB11041 to P-selectin as measured by a competitive inhibition assay.
Patent NZ-273973-A (NZ)
Title: Composition for oral administration comprising a "substance", a water insoluble polyamide or ethylene copolymer, lipid substance having a lower melting point than the polymer and a palatable substance/attractant
Inventor: DERRIEU GUY
IPC: A23K1/18
Filed: 1994-09-27
Abstract: PCT No. PCT/FR94/01120 Sec. 371 Date May 22, 1996 Sec. 102(e) Date May 22, 1996 PCT Filed Sep. 27, 1994 PCT Pub. No. WO95/08931 PCT Pub. Date Apr. 6, 1995Composition and system for oral administration of chemicals or medicaments, and applications thereof (for example as medicament, dietetic product, food product, bait). Said composition comprises essentially (a) from 3% to 20% by weight of at least one water-insoluble polymer selected from the polyamides and ethylene copolymers such as ethylene/vinyl acetate; (b) from 35% to 60% by weight of lipidic substances, at least one of these lipidic substances being solid at room temperature, the melting point of the solid lipidic substance(s) being lower than that of the polymer(s); (c) from 5% to 45% of at least one paletable substance; (d) from 0% to 50% of another suitable complementary ingredient. Said composition can be obtained by (i) melting of the solid lipidic substances at a temperature lower than the melting point of the polymer(s), and (ii) mixing of the polymer(s) and the other constituents at the same temperature as for (i). A method of preparing said systems and composition is also disclosed.
Patent NZ-281146-A (NZ)
Title: Antigenic preparation of helicobacter bacteria lipopolysaccharide and its use in treating helicobacter infection
Inventor: DOIDGE CHRISTOPHER VINCENT
IPC: A61K39/395
Filed: 1995-02-17
Abstract: An antigenic preparation for use in the treatment or prevention of Helicobacter infection in a mammalian host, comprises the lipopolysaccharide (LPS) of Helicobacter bacteria, particularly the LPS of H. pylori or H. felis, or an immunogenic fragment thereof.
Patent NZ-295998-A (NZ)
Title: Neutralizing antitoxins against clostridium difficile and clostidium botulinum toxins
Inventor: WILLIAMS JAMES A
IPC: A61P31/04
Filed: 1995-10-23
Abstract: The present invention provides neutralizing antitoxin directed against C.difficile toxins. These antitoxins are produced in avian species using soluble recombinant C.difficile toxin proteins. The avian antitoxins are designed so as to be orally administrable in therapeutic amounts and may be in any form (i.e., as a solid or in aqueous solution). Solid forms of the antitoxin may comprise an enteric coating. These antitoxins are useful in the treatment of humans and other animals intoxicated with at least one bacterial toxin. The invention further provides vaccines capable of protecting a vaccinated recipient from the morbidity and mortality associated with C.difficile infection. These vaccines are useful for administration to humans and other animals at risk of exposure to C.difficile toxins.
Patent NZ-302741-A (NZ)
Title: Mucoadhesive carbomer granules for gastric medication
Inventor: DETTMAR PETER WILLIAM
IPC: A61K9/16
Filed: 1996-03-05
Abstract: Mucoadhesive granules comprisinga) carbomer and/or a salt thereof; andb) an inert filler.The granules preferably further comprise a pharmaceutically active agent suitable for sustained release into the gastrointestinal tract or for targeted delivery to the gastrointestinal mucosa.
Patent NZ-305802-A (NZ)
Title: Process for the manufacture of hypochlorite bleaching compositions
Inventor: TRIGIANTE GIUSEPPE
IPC: C01B11/06
Filed: 1996-04-19
Abstract: he present invention discloses a process for the manufacture of liquid aqueous bleaching compositions comprising hypochlorite, a strong source of alkalinity and water.  The process comprisies the steps of: mixing said alkali metal hypochlorite, said strong source of alkalinity and said water; adding a precipitating agent, or mixtures thereof; and thereafter separating the precipitates formed from said composition. The compositions provided by the process according the present invention are substantially free of heavy metal ions, thereby providing improved whiteness performance and/or fabric safety performance.
Patent NZ-333450-A (NZ)
Title: Method and arrangement for nondestructive classification by measuring acoustic resonance frequencies of object
Inventor: LARSSON DANIEL
IPC: G01N3/30
Filed: 1997-06-17
Abstract: Method and device for non-destructive determination of rigidity, strength and/or structural properties of preferably oblong and/or plate-shaped objects (11), alternatively determination of the geometrical dimensions of the object, through impact excitation and registration of resonance frequencies of natural modes of the object. Resonance frequency from at least one of the natural modes of the object is used, which resonance frequency is achieved by bringing the object (11) in vibration by means of a stroking body (24, 31, 38), and substantially controlling the initiation of the motion of the stroking body (24, 31, 38) and subsequent physical impact in time and space by motion of the object (11).
Patent NZ-334811-A (NZ)
Title: Strain selection of pneumococcal surface proteins
Inventor: BECKER ROBERT S
IPC: C07K14/715
Filed: 1997-09-22
Abstract: Disclosed is a vaccine composition(s) comprising at least two PspAs from strains selected from at least one family, the family being defined by PspAs from strains belonging to the family having greater than or equal to 50 % homology in aligned sequences of a C-terminal region of an alpha helical region of PspA. Additionally, the families are further comprised of clades, wherein PspAs from strains which belong to a clade exhibit at least 75 % sequence homology in aligned sequences of the C-terminal region of the alpha helix of PspA. Vaccine compositions of the present invention preferably comprise a minimum of 4 and a maximum of 6 strains representing a single clade each, and the at least two PspAs are optionally serologically or broadly cross-reactive.
Patent NZ-335411-A (NZ)
Title: Washer, typically dishwasher, with chamber sliding in cabinet being top sealed after retraction by closure moving vertically
Inventor: MAUNSELL STEVE
IPC: A47L15/00
Filed: 1997-01-30
Abstract: Peripheral resilient sealing member 20 is disposed on the underside of lid 217.  Inflatable annular member 21 is used to force lid 217 down against rim 19 of a wash chamber.
Patent NZ-336869-A (NZ)
Title: Pharmaceutical compositions comprising aqueous alcoholic Centipeda plant extracts
Inventor: CLOSE GRAEME A
IPC: A61Q11/00
Filed: 1998-01-22
Abstract: Described is a pharmaceutical composition which comprises an aqueous alcoholic extract from the plant Centipeda Cunninghamii or related Centipeda species. The extract is an extract of plant material with aqueous ethanol. The abovementioned Centipeda plant extracts are useful in a range of cosmetic, therapeutic and prophylactic applications, particularly in the treatment of skin disorders.
Patent NZ-337545-A (NZ)
Title: Table having a top and corrugated support ends
Inventor: MILLER TIMOTHY JOHN
IPC: A47B7/00
Filed: 1998-07-10
Abstract: furniture item comprises an article supporting member 1 including an edge 3 and a member 2 formed of corrugated material attached to article supporting member 1 along  edge 3 to retain article supporting surface 1 at a predetermined height.  Edge 3 of article supporting member 1 is formed with complementary corrugations into which the corrugations of the member formed of corrugated material 2 engages.
Patent NZ-500208-A (NZ)
Title: Buffer assignment and addressing in a computer memory particularly for MPEG decoder
Inventor: MERIC JEROME
IPC: H04N21/443
Filed: 1998-03-19
Abstract: In a memory in a computer system, a plurality of buffer zones are defined by a buffer management system. A command defines a number NP of pools of buffers in a public buffer zone, and for each pool, a pool size PS of the number of buffers in the pool and the size BS of the buffers in that pool. The buffer management system is initialised to store, for each buffer zone, the buffer sizes and to cumulate and store the pool sizes. To address a buffer, the buffer management system determines the address of the start of the buffer from the desired pool and buffer numbers, using the stored information. The buffer management system also defines a header at the beginning of each buffer. Checking for out-of-limits conditions can also be provided. Various private buffer zones allocated to respective different clients, can be similarly defined.
Patent NZ-502466-A (NZ)
Title: Nucleic acid molecules and their use in the control of male plant sterility
Inventor: SINGH MANJIT
IPC: A01H5/00
Filed: 1998-07-24
Abstract: Described is a nucleic acid molecule, more particularly, a male germ line cell specific genetic sequence in plants.  Male germ line cells include generative cells and sperm cells.  Even more particularly, a male germ line specific gene or functional equivalent thereof is described.  Also described is the promoter of the gene or its functional derivatives.  Also described is their use in generating a range of mutant plants including male sterile plants and transposon tagged plants.
Patent NZ-502674-A (NZ)
Title: Composition comprising Mycobacterial phlei DNA and/or cell wall extract from M. phlei for treating cancer
Inventor: PHILLIPS NIGEL C
IPC: A01N63/00
Filed: 1998-08-05
Abstract: A composition and method useful for regulating cell proliferation and cell death in a multicellular organism. The present invention particularly relates to a composition comprising a bacterial DNA (B-DNA) and a first pharmaceutically acceptable carrier, wherein the B-DNA induces a response in responsive cells of an animal. More particularly it relates to a composition comprising a mycobacterial DNA (M-DNA) and a first pharmaceutically acceptable carrier, wherein the M-DNA inhibits proliferation of responsive cells of an animal, induces apoptosis in responsive cells of an animal, and stimulates responsive cells of the immune system of an animal to produce bioactive molecules. Methods of making the M-DNA composition and methods of using the M-DNA composition also are described.
Patent NZ-504040-A (NZ)
Title: Cyclopentene derivatives useful as antagonists of the motilin receptor
Inventor: CHEN ROBERT H
IPC: C07D213/81
Filed: 1998-10-27
Abstract: The compounds of formula (I) are useful in treating gastrointestinal disorders associated with antagonizing the motilin receptor disorders. The compounds compete with erythromycin and motilin for the motilin receptor. In addition the compounds are antagonists of the contractile smooth muscle response to those ligands.
Patent NZ-507456-A (NZ)
Title: Process and conjugated forms of PEGylated interferon- beta with polyethylene glycol (PEG) wherein the thiol reactive polyol agent is mono-methoxylated
Inventor: EL TAYAR NABIL
IPC: A61K47/48
Filed: 1999-04-28
Abstract: A polyol-interferon-â conjugate having a polyol moiety (which is a polyethylene glycol (PEG) moiety) covalently bound to Cys17 of human interferon- â. The above-described compound may be used to treat infections, tumors and autoimmune diseases. A method for stepwise attachment of PEG moieties in series to a polypeptide.
Patent NZ-515129-A (NZ)
Title: Dynamic skill-based call routing
Inventor: DOYLE ROBERT
IPC: H04M3/50
Filed: 2000-04-13
Abstract: Agents of an automatic call distributor are assigned to incoming calls being of a plurality of different call types.  A target occupancy matrix including a target occupancy for each agent for each call type is determined.  A call of a first type of the types determined in the target occupancy matrix is processed and assigned to an agent with the largest relative difference between an actual occupancy of calls of the first type handled by the agent and the target occupancy of calls of the first type determined for the agent in the target occupancy matrix.
Patent NZ-515380-A (NZ)
Title: Aqueous stable preserved pharmaceutical compositions of erythropoietin
Inventor: CHEUNG WING K
IPC: A61K47/10
Filed: 2000-04-07
Abstract: A pharmaceutical formulation comprises a pH buffering agent, a stabilizing amount of human serum albumin, a stabilizing amount of an amino acid, an antimicrobial quantity of cresol and erythropoietin and optionally an tonicity agent. Also described are formulations comprising either 10000, 25000 or 40000 IU erythropoietin, 6.25mg or 5mg human serum albumin, 2.91mg or 2.33mg sodium phosphate monobasic dihydrate, 11.19mg or 8.95 sodium phosphate dibasic dodecahydrate, 50mg or 40mg glycine, 7.50mg or 6.0 mg m-cresol adjusted to 2.5ml with water and a urea-free, non-lyophilized pharmacuetical formulation comprising 2000, 4000, 10000 or 40000 IU erythropoietin, 4.38mg sodium chloride, 1.16mg sodium phosphate monobasic dihydrate, 2.23mg sodium phosphate dibasic, 5mg glycine, 0.30mg Polysorabte 80 adjusted to 1ml with water
Patent NZ-516861-A (NZ)
Title: Bread toasting control in a toaster by response curve of photosensitive element (light reflectivity of the toast)
Inventor: BATTU CLAUDE
IPC: A47J37/08
Filed: 2000-06-30
Abstract: Method for controlling the grilling, or toasting, of a food product placed in a grilling appliance of the toaster (1) or oven type, the appliance comprises, in particular: heating elements (4), a heating chamber (5), a grilling selector for adjusting the level of browning of the food product, means permitting stopping the supply of electricity to the heating elements when the level of toasting is achieved, the device has a light receiving system composed of at least one photo-sensitive element of the LDR type (42), the light reflected by the food product which is grilled or toasted is brought up to the surface of the element(s), wherein it consists in measuring the evolution in time of a signal G representative of the light reflectivity of the food product , and converting at least one characteristic of that evolution into at least one of the grilling or tasting states of the food product.
Patent NZ-517544-A (NZ)
Title: Use of paciitaxel, analogue or derivative thereof possibly comprising a polymer, to treat or prevent diseases associated with fallopian tubes
Inventor: HUNTER WILLIAM J
IPC: A61K31/00
Filed: 1997-05-24
Abstract: Described is the use of paclitaxel, or analogues and derivatives thereof in the manufacture of medicaments to prevent or treat diseases of the fallopian tubes. The medicaments may further comprise a polymer such as poly(ethylene-vinyl acetate), copolymers of lactic acid and glycolic acid, poly (caprolactone), poly (lactic acid), copolymers of poly (lactic acid) and poly (caprolactone), gelatin, hyaluronic acid, collagen matrixes, and albumen.
Patent NZ-520485-A (NZ)
Title: DNA encoding human vanilloid receptor VR3, and method for identifying compounds that modulate the receptor protein
Inventor: DUBIN ADRIENNE ELIZABETH
IPC: A61K48/00
Filed: 2001-02-01
Abstract: An isolated and purified nucleic acid molecule which encodes a human Vanilloid Receptor 3 (VR3) protein which comprises the amino acid set forth in SEQ ID NO:7 is described. Preferably the nucleic acid sequence is Seq ID No: 5 and 6. Also described are vectors and recombinant host cells comprising the DNA encoding the VR3 protein and process for expression of the protein.
Patent NZ-521932-A (NZ)
Title: Determining intra-day net asset value proxy of an actively managed exchange traded fund
Inventor: GASTINEAU GARY L
IPC: G06Q40/00
Filed: 2001-03-27
Abstract: A method of determining an intra-day asset value proxy for an exchange traded fund which comprises of receiving a file having adjusted portfolio security position information in the exchange traded fund in an encrypted format; decrypting the file having the adjusted portfolio information to provide the security positions in the exchange traded fund portfolio; and calculating the intra-day net asset value proxy for the fund by applying prices received from a quote feed to the security positions in the exchange traded fund portfolio wherein the security positions of the fund are kept confidential.
Patent NZ-524510-A (NZ)
Title: Creatine ester pronutrient compounds and formulations
Inventor: VENNERSTROM JONATHAN L
IPC: A23L1/30
Filed: 2001-09-14
Abstract: A method for providing creatine to a non-human animal, comprising: administering a creatine ester to the animal, and modification of the creatine ester in vivo, wherein the creatine ester is suitable for being modifies by the animal to form creatine, is disclosed. The ester derivative of creatine may be suitable for acting as a pronutrient in an animal. A food supplement comprising a creatine ester suitable for being modified by an animal to form creatine is also described. A composition of matter of formula (I) is disclosed, wherein R represents an ester and wherein the composition of formula (I) is suitable for being converted to creatine upon administration to an animal. A method of producing a creatine pronutrient, comprising: reacting at least one of an anhydrous creatine and hydrated form of creatine with an alcohol in an acidic environment, wherein a product is formed including a creatine ester pronutrient.
Patent NZ-524837-A (NZ)
Title: Adjustable anti-splitting device
Inventor: MURRAY NORMAN E
IPC: B25D1/04
Filed: 2001-08-31
Abstract: The anti-splitting device (10) has a central-web portion (14) and a pair of end web portions (16, 18), which are joined adjacent to their midpoints to opposite ends of the central web portion to provide the device with generally I-shaped cross-sectional configurations.  The web portions have first side edges tapered to define a cutting edge (24) and second side edges serving to define a planar driven surface (26) disposed parallel to the cutting edge.  And on the central web portion are at least two projections (20, 22) to upstand from driven surface.  The projections are adapted to removably attach the device to a driver employed to insert the device into a log.  The driver (12) is preferably in the form of a manually operational hammer having a planar driver surface (38) of circular plan form configuration and a circular groove (40) that has an outer diameter equidistant and an inner diameter equidistant from a given fixed point, the centre of the planar driving surface.  The groove receives the projections and contacts a predetermined portion of the projections; the projections exert a force on either the outer diameter or the inner diameter, and do not contact both diameters at the same time.  The device can then be freely rotated in the groove to obtain a desired position on the driver surface.
Patent NZ-525810-A (NZ)
Title: Slowly digestible starch product
Inventor: SHI YONG-CHEN
IPC: A23L7/10
Filed: 2003-05-13
Abstract: A starch composition prepared from amylose-containing starch comprising crystalline linear á-glucans characterised by: (a) at least about 20% slowly digestible starch; (b) less than about 50% rapidly digestible starch; (c) a melting point temperature, Tp as measured b DSC, of at least about 70°C; and (d) an enthalpy, ÄH as measured by DSC, of at least about 25J/g, a process for making the composition and an edible product comprising the composition.
Patent NZ-525822-A (NZ)
Title: Mineral wool element with enhanced reaction to fire, air duct comprising same
Inventor: RODERO ANTUNEZ CARLOS
IPC: C03C25/26
Filed: 2001-11-30
Abstract: An element for manufacturing panels for the construction of air ducts is disclosed, which comprises mineral wool and exhibits enhanced reaction to fire. The panels comprise a mineral wool core to which an adhesive is added, wherein the core is formed with glass fibres which act as wool constituents, and wherein the adhesive is added in an amount between 5% and 6%. The glass fibres of the element have a diameter substantially greater relative to the glass fibres used conventionally for making panels or ducts for similar purposes. The glass fibres used in the element for manufacturing panels have a fineness index of value ranging between 5.8 ± 0.5 for 6 grams. A method for making an air duct from the panels is also disclosed.